If you are building a private label face serum, niacinamide is probably the first ingredient your customers name before you have finished the pitch. It is the rare active that is genuinely familiar — consumers recognize it, retailers stock it, and formulators trust it — while still leaving real room for brand differentiation. That room is not in the ingredient itself; it is in the concentration architecture, the pH management, the compatibility decisions and the stability evidence behind the label. This guide breaks down how niacinamide works, what the EU 5% limit means for your formula, which concentrations the evidence actually supports, and the questions to put in front of an OEM partner before you commit to a niacinamide serum project.
The reference platform for this guide is Lanthome's Natural Vitamin C Herbal Turmeric Niacinamide Serum — a 30 ml liquid serum that pairs niacinamide with vitamin C, turmeric and aloe as a multi-active daily treatment. We use it as the concrete example whenever the chemistry gets practical, and it sits in the Serum collection as one of the line's flagship treatment formats.
Niacinamide is the amide form of vitamin B3. On an INCI label it appears simply as "Niacinamide," and in the lab it presents as a colorless, water-soluble solid — one of the most economical functional actives available to a cosmetic formulator, and one of the easiest to dose consistently across batches.
A quick disambiguation, because it comes up in every buyer conversation. Vitamin B3 exists in two main cosmetic forms: niacin (nicotinic acid) and niacinamide (nicotinamide). Niacin at meaningful topical concentrations can cause visible flushing and tingling, which is why virtually every B3 skincare product is built on the amide form instead. If a product makes you feel warm on your face, that is usually niacin chemistry — or niacinamide that has converted to it (more on that in the stability section).
Niacinamide also deserves the "platform ingredient" label. The term describes an active that anchors an entire range — cleanser, serum, moisturizer, mask — under one brand story, the way hyaluronic acid did for hydration in the 2010s. For a private label line, that matters commercially: a customer who already trusts a niacinamide serum is a customer who will buy the niacinamide moisturizer next, with almost no education cost.
In 2026, niacinamide's strategic position is a bit different. Hero ingredients such as PDRN and blue copper peptides are taking the headlines — our 2026 K-Beauty trend guide for PDRN face creams covers that shelf in depth — while niacinamide has moved into the supporting cast. It is the familiar name that makes a newer formula feel credible, the barrier-and-tone workhorse that pairs with almost anything. For a private label buyer, that dual status is exactly what makes it interesting: a safe default that still differentiates, provided you get the architecture right.
Here is where "vitamin B3" marketing usually outpaces evidence, so let's separate what the peer-reviewed record supports from what labels tend to promise. The Cosmetic Ingredient Review (CIR) Expert Panel's final safety assessment of niacinamide and niacin (2005) is the reference document: it concluded that niacinamide is safe for use in cosmetics at the concentrations and conditions of use typical of leave-on products.
This is the most-cited and best-supported lane. Niacinamide is commonly used in formulations positioned around the skin's natural lipid balance and overall barrier comfort. You will see it in sensitive-skin lines, post-exfoliation routines and "repair" serums. The claim language that stays on the right side of the line is appearance and comfort: "supports a comfortable, balanced-looking complexion," not "repairs damaged skin."
The second commercial lane is the appearance of an even complexion and the look of dark spots. The mechanism most often cited in the literature is an effect on how melanin is transferred between cells — a cosmetic-appearance claim, not a bleaching or medical one. This is the lane where brands get most creative, and the one that most needs conservative wording.
Clinical work on topical niacinamide — including the 2% cream study by Bissett et al. and the broader survey of cosmeceutical evidence in the Journal of the American Academy of Dermatology — has reported improvements in the appearance of pores and in sebum levels in some study designs. If your positioning targets combination or oily-leaning skin, this is the evidence lane to lean on — with "appearance" doing the heavy lifting in every sentence.
Niacinamide participates in cellular energy pathways as a precursor to NAD+, which is the scientific basis for its antioxidant positioning in daily-wear products. This is a quieter claim than the others, but it is a useful one: it lets a serum carry a "daily defense" story without stepping into treatment language.
One more note on the boundary. All four lanes are cosmetic-appearance and comfort claims. Language that implies diagnosis, treatment or prevention of a skin condition crosses into drug territory in the US and into off-scope claims in the EU. The difference between a shippable label and a compliance problem is usually two words: "appearance" and "look."
There is one regulatory number that matters more than any other for a niacinamide product, and it applies to the EU.
EU — a hard 5% ceiling. Under Annex III to Regulation (EC) No 1223/2009, the EU Cosmetics Regulation, niacinamide is listed as a restricted substance with a maximum concentration of 5% in the finished product. The practical consequence is worth stating plainly: a "10% niacinamide serum" cannot be sold in the EU as formulated. If you plan to stock an EU warehouse, list on an EU marketplace, or supply a European retailer, the formula itself must be rebuilt at or below 5% — this is not a relabeling exercise.
US — no concentration limit, claim discipline instead. In the United States, the FDA regulates cosmetics by claims and ingredient safety rather than by concentration caps; there is no maximum niacinamide level for cosmetic products. The same caution from the previous section applies: the label must describe appearance and cosmetic effects, not the treatment of conditions.
Elsewhere. Most markets follow the INCI nomenclature and local restriction lists; where the EU list is used as a baseline, the 5% figure is the safe working assumption. If you are selling into a specific market, confirm the local restriction entry with your partner before freezing the formula.
| Market | Regulatory position | Practical implication |
|---|---|---|
| EU / EEA | Restricted: max 5% in finished product (Annex III, Reg. 1223/2009) | Formula capped at 5%; no "10%+" positioning possible |
| US | No concentration limit; claims must stay cosmetic | 5% and above both allowed; claim language is the constraint |
| Other markets | INCI listing; local restriction checks apply | 5% is the safe working baseline for multi-market formulas |
Two labeling notes. First, the INCI name on the label is simply "Niacinamide," listed in descending order by weight — consumers cannot see your percentage from the label, which is exactly why the concentration belongs in your technical documentation and your marketing claim file, not on the front of the pack. Second, the 5% cap applies to the final product: if you co-pack or blend after manufacturing, the calculation still has to hold at the point of sale.
The evidence base for topical niacinamide is narrower than the marketing would suggest. Almost all of the cited clinical work sits in the 2–5% range, and that range is where you should build.
The classic reference is the 2% niacinamide cream study by Bissett et al. (2005), which reported improvements in the appearance of fine lines, wrinkles, elasticity and skin roughness — the study most frequently cited in the cosmeceutical literature, alongside later work by Matts and Solenick at 2% and 5% showing that the effects trend with dose. The JAAD review of cosmeceutical ingredient evidence is a useful summary of the whole literature for anyone building a claim file.
From that record, three practical conclusions:
| Concentration | Typical positioning | Buyer consideration |
|---|---|---|
| 1–2% | Gentle daily, sensitive-skin lines | Lowest sensitivity risk; barrier-comfort story; still above the "trace" zone |
| 2–5% | Mainstream treatment serums | The evidence-supported window; 5% works in the EU and tops the cited range |
| 10%+ (non-EU only) | Bold "maximum strength" claims | Rising sensitivity reports; heavier stability burden; unsellable in the EU as formulated |
The buyer takeaway is that concentration is a claim, and claims need documentation. Ask your OEM partner for the actual percentage and the raw material certificate of analysis (COA). "Niacinamide" on the front panel is marketing; the COA and formula sheet are what make it true.
Niacinamide is one of the easier actives to stabilize — which is precisely why brands underestimate the system around it.
The pH window. In its amide form, niacinamide is stable across a mildly acidic to neutral range, roughly pH 5–7. Serum platforms built around it typically land near pH 5.0–5.5, which also happens to be the comfortable operating range for most broad-spectrum preservative systems. That alignment is no accident: a well-designed niacinamide serum chooses its pH once, and lets the preservative, the active and the skin-comfort all sit inside the same window.
The conversion pathway. Under certain conditions — heat, pH drift, or specific chemical environments — niacinamide can convert to nicotinic acid (niacin). This is the pathway the CIR assessment flags for monitoring, and it is the chemical explanation behind the "flushing" complaints some users attribute to niacinamide products: they may actually be experiencing trace niacin. Holding the final formula in the mid-pH range and running proper stability cycles is the standard way to keep that conversion minimal over a full shelf life.
Multi-active systems change the math. A serum that stacks niacinamide with vitamin C, botanicals or acids is no longer judged by one ingredient's stability profile — it is judged as a system. Color drift (vitamin C oxidizing, turmeric deepening), odor development and pH migration over time are the things that show up in accelerated testing, and the things your customers will notice first. If the reference platform lists a 3-year shelf life, that number should be backed by accelerated and long-term stability data, not by the raw material's.
This is where a second, deeper reference helps: our TXA + Niacinamide Capsule Cream Formulation Guide walks through the same pH and stability logic for a cream base — useful if your plan includes a niacinamide moisturizer alongside the serum.
What to request from any OEM partner, in writing: the final formula pH, the COA for the niacinamide raw material, the stability protocol (accelerated plus long-term cycles), and the resulting shelf life. A manufacturer that answers all four is treating the formula as a system rather than a shopping list.
The practical reason brands reach for niacinamide is that it is one of the most pair-friendly actives in cosmetic chemistry. It tolerates peptides, hyaluronic acid, most botanicals and — handled properly — vitamin C. The pairings that actually need management:
The "niacinamide and vitamin C cancel each other out" story is the most persistent myth in skincare, and the modern consensus is more nuanced. L-ascorbic acid serums run at a low pH (around 3 or below) to stay active, and at very low pH there is a theoretical pathway toward niacinamide converting to niacin — which is where the flush anxiety comes from. In practice, the two can coexist in a well-managed formula: the formulator controls the final pH, may use a more stable vitamin C derivative, or designs the product so each active does its work at a different routine step. The conservative, correct position: in-formula coexistence is achievable, and the burden of proof sits with the pH data and the stability cycles — ask for both.
For AHA/BHA combinations, the routine-level answer is usually enough: one active in the morning routine, the other in the evening, with a moisturizer as the buffer. In-formula combinations are generally built at lower doses, and the same pH-discipline logic applies.
Here the reference serum is instructive. Turmeric — the main ingredient in that formula — brings its own stability considerations, around color and pH overlap; our turmeric ingredient science guide covers where both ingredients stay stable. Aloe and most herbal extracts are the easy side of the compatibility table: they contribute comfort and texture without forcing a pH compromise. For the broader brightening stack — including how niacinamide sits alongside glutathione in multi-active systems — the glutathione compatibility section in our earlier guide is a good companion read.
| Co-active | Interaction to manage | Typical formulation response |
|---|---|---|
| Vitamin C (L-ascorbic acid) | Low pH of the C phase; theoretical conversion pathway | Control final pH, or use a stable derivative, or split by routine step |
| AHA / BHA | Acidity and exfoliation load | Lower in-formula doses; AM/PM routine split for consumer use |
| Turmeric and botanicals | Color management; pH overlap between actives | Confirm the shared pH window; monitor color over stability cycles |
| Peptides, hyaluronic acid | Minimal — both stable in the 5–7 window | Standard inclusion; check peptide heat sensitivity if applicable |
The pattern across all four rows is the same: compatibility is not a property of the ingredient pair, it is a property of the finished formula. That distinction is what separates a supplier that formulates from one that assembles.
Let's make this concrete with the reference product: Lanthome's Natural Vitamin C Herbal Turmeric Niacinamide Serum.
The platform is a 30 ml (1.01 fl.oz) liquid serum for the face and neck, listed with turmeric as the main ingredient and vitamin C, herbal and organic ingredients on the profile, with a function stack of turmeric, blood orange and aloe. The listed effects — improve skin's elasticity, revive skin tone and texture, improve the skin's protection — are all written in cosmetic-appearance language, which is exactly the register a compliance-ready label needs.
Read as an architecture, the formula divides the claim lanes deliberately:
Each active owns one lane, so no single ingredient is asked to overclaim — and niacinamide sits comfortably as a supporting active within the 5% EU ceiling, which keeps the formula exportable to both sides of the Atlantic without a rebuild.
The multi-active reality still shows up in the physical product. Turmeric is golden and vitamin C degrades with light and time, so color management is a first-order design decision, not a finishing detail. The platform lists a 3-year shelf life and an MSDS document, and ships as a single item in a 7 × 7 × 15 cm package (0.072 kg gross) — compact enough that a brand can add it to an existing range without touching warehouse logistics. The directed usage — 2–3 drops, morning and night, followed by a moisturizer — is a dosing format that suits a supporting-active architecture: enough to work, not enough to irritate.
If this shape fits your plan, the Serum collection shows the full range of liquid treatment platforms available for customization, from single-active serums to multi-actives in the style of this one.
Before you commit a niacinamide serum to production, put these questions in writing:
These questions do not cost anything to ask, and they filter out most of the suppliers that cannot answer them. You can reach the Lanthome team directly through the Contact Us page — a formula question with a concentration, a pH and a target market attached gets a faster, sharper answer than a generic inquiry. And if you want to understand what the manufacturing side of this looks like — GMP factory, export license, project structure — the About Us page covers Lanthome's capabilities and OEM/ODM services.
What is the maximum niacinamide concentration allowed in EU cosmetics?
Five percent in the finished product. Niacinamide is listed in Annex III to Regulation (EC) No 1223/2009 with that limit, so a 10% niacinamide serum cannot be sold in the EU as formulated — it would need a formula rebuild at or below 5%.
Is 10% niacinamide better than 5%?
The cited clinical work sits in the 2–5% range and trends with dose within it; above 5%, the additional benefit flattens while sensitivity and stability concerns rise. In the EU, the question is answered by law: 5% is the ceiling.
Can I use niacinamide together with vitamin C?
In a well-managed formula, yes. The historical concern was the low pH of L-ascorbic acid systems and a theoretical conversion pathway; modern practice handles it through final-pH control or stable derivatives. The right question for your supplier is what pH the finished formula runs at and what stability data covers the combination.
Why do some "B3" products cause flushing?
Visible flushing is characteristic of niacin (nicotinic acid), not niacinamide. If a niacinamide product flushes, the likely cause is trace conversion to niacin from pH or storage conditions — which is why the pH window and stability testing in the previous section matter commercially, not just technically.
What is the difference between niacinamide and vitamin B3?
Vitamin B3 is the family; niacin and niacinamide are its two main cosmetic forms. Niacinamide is the amide form used in skincare because it delivers the benefits without the flushing associated with niacin at comparable concentrations.
How long does it take to get a private label niacinamide serum?
On the reference platform, production is listed at about 5–25 days after deposit confirmation, depending on order and quantity, with the private label factory-price step starting at 3,000 pcs. Most projects begin with samples, so add the sampling round trip in front of that window.
About the Author
This article was prepared by the Lanthome skincare manufacturing team, with experience in private label formulation, packaging development, quality control, and international OEM/ODM projects.
